Council Members in this Study Group: 341
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Jeffrey Gosin, M.D.Attending Surgeon and Chief of Vascular Surgery
SHORE MEMORIAL HOSPITAL ![]()
Jeffrey Gosin, MD, is a Physician and Vice President at Jersey Shore Surgical Group in New Jersey, since July 1997. Dr. Gosin is also an Attending Surgeon and Chief of Vascular Surgery at Shore Memorial Hospital. He also serves as a Medical Director of the Cardiovascular Institute, a multidisciplinary...
Jeffrey Everett, MDDirector of Minimally Invasive and Robotic Surgery
UNIVERSITY HEALTH SYSTEM, INC. ![]()
Jeffrey E. Everett, MD, is Director of Minimally Invasive and Robotic Cardiac Surgery and Associate Professor of Cardiothoracic Surgery at the University of Tennessee Medical Center. Previously, he was Director of Heart Transplantation, Minimally Invasive and Robotic Cardiac Surgery, and AssociateProfessor...
Cardiac, Thoracic and Vascular Surgeon
Rubenstein Cardiovascular and Thoracic Surgery ![]()
Forrest Rubenstein, MD, FACS, is a Cardiac, Thoracic and Vascular Surgeon in private practice. Dr. Rubenstein is board certified in General, Cardiovascular and Thoracic Surgery. He has experience in cardiac, thoracic and vascular surgery, aortic surgery, trauma, endovascular surgery, drug eluting stents,...
Robert Gorman, MDAssociate Professor
University of Pennsylvania - CC ![]()
Robert Gorman, MD, is an Associate Professor and Director of Cardiac Surgical Research at the University of Pennsylvania. He is board certified Cardiothoracic Surgeon with clinical interests in adult cardiac surgery with a particular emphasis in valvular heart disease, aortic disease, ventricular assist...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Watchman trial: right device, wrong patient population.
April 3, 2009
ACC: Device May Prevent Stroke in AF Patients | www.medpagetoday.com
1. Left atrial appendage is not the only source of systemic thromboemboli. Thrombi form in the rest of the left atrium and even in the ventricle. 2. The trial did not address issues of thrombogenicity of the device by itself. 3. "Pericardial effusion" was not an effusion, but a bleeding from the...
April 3, 2009
U.S. Hospitals Slow to Adopt E-Records | online.wsj.com
While the majority of hospitals have some degree of EMR, none have truly "fully functional" EMR. EMR: 1. Do not increase profit, do not increase productivity, do not save time, do not increase quality of care; 2. Do increase potential for litigations, do increase degree of control of clinicians...
Darusentan and Resistant Hypertension
April 2, 2009
Phase III Study of Gilead's Darusentan for Resistant Hypertension Meets Primary Endpoints | investors.gilead.com
The most recent press release from Gilead Scienes, Inc. (Nasdaq: GILD) re: phase III study of Darusentan, a novel endothelin receptor antagonist, designed to control resistant hypertension. The effectiveness in controlling systemic blood pressure was found to be statistically significant. Incidence...
Multivitamins, filtered water, shark cartilage, black magic etc.
March 10, 2009
Multivitamins: Fact or Fiction | www.usatoday.com
Treatment modalities given for symptoms rather than for treatment of correctly diagnosed diseases by definition must have no effect since the same symptoms (headache) might be produced by different and often opposite conditions (low vs. high blood pressure). The same applies toprevention...
Important Revelation with no Sequences.
December 10, 2008
Generic Heart Drugs as Good as Brand-Name Counterparts | www.washingtonpost.com
No doubt generic and brand-name drugs are the same or almost the same not only in cardiovascular medicine, but in majority of other applications as well. It is not a surprise: companies are not going to study generic drugs in search of new benefits. There are some advantages, however, of brand-name...